Breaking News

Has no content to show!

Pharmaceutical News

Lupin acquires US firm Symbiomix Therapeutics for $150 million

Lupin Ltd on Wednesday said its US subsidiary has acquired Symbiomix Therapeutics LLC for a cash consideration of $150 million in a bid to expand its presence in women’s health segment.


Novartis India board clears share buyback worth up to Rs231 crore

Novartis India Ltd on Monday said its board of directors approved share buyback worth up to Rs231 crore.


OTC medicines: Drug advisory body gives in-principle approval

Soon, pharmacists will be able to dispense drugs for minor conditions without a doctor’s prescription.


Dr Reddy’s says German regulator makes 6 observations on its Duvvada unit

Dr. Reddy’s Laboratories said on Friday a German regulator has made six major observations about its Duvvada drug making facility in the southern Indian state of Andhra Pradesh,


About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners